Literature DB >> 1026533

Some aspects of the clinical pharmacology of intravenous disopyramide after myocardial infarction.

W S Hillis, A Tweddel, A R Lorimer, T D Lawrie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1026533

Source DB:  PubMed          Journal:  J Int Med Res        ISSN： 0300-0605            Impact factor:   1.671


× No keyword cloud information.
  6 in total

1.  Haemodynamic effects of disopyramide in patients after open-heart surgery.

Authors:  N Naqvi; D S Thompson; W E Morgan; B T Williams; D J Coltart
Journal:  Br Heart J       Date:  1979-11

2.  Effect of concentration-dependent binding to plasma proteins on the pharmacokinetics and pharmacodynamics of disopyramide.

Authors:  K M Giacomini; T F Blaschke
Journal:  Clin Pharmacokinet       Date:  1984-01       Impact factor: 6.447

3.  The effect of saturable binding to plasma proteins on the pharmacokinetic properties of disopyramide.

Authors:  K M Giacomini; S E Swezey; K Turner-Tamiyasu; T F Blaschke
Journal:  J Pharmacokinet Biopharm       Date:  1982-02

4.  Haemodynamic effects and kinetics of concomitant intravenous disopyramide and atenolol in patients with ischaemic heart disease.

Authors:  J Bonde; L E Pedersen; H R Angelo; J Trap-Jensen; T L Svendsen; J P Kampmann
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

5.  The effects of disopyramide phosphate on early post-coronary artery ligation dysrhythmias and on epicardial ST-segment elevation in anaesthetized dogs.

Authors:  R J Marshall; J R Parratt
Journal:  Br J Pharmacol       Date:  1979-06       Impact factor: 8.739

6.  Negative inotropic effects of disopyramide on guinea-pig papillary muscles.

Authors:  N Kondo; M Mizukami; S Shibata
Journal:  Br J Pharmacol       Date:  1990-12       Impact factor: 8.739
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.